|
OMIM |
Link |
Information gain |
01 |
|
deafness, congenital, and onychodystrophy, recessive form
|
[NCBI]
|
0.00192174
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.00138001
|
|
|
stomatocytosis i
|
[NCBI]
|
0.0012111
|
|
|
GPS
|
[NCBI]
|
0.00109578
|
|
|
SLC6A3
|
[NCBI]
|
0.000410008
|
|
|
SLC6A4
|
[NCBI]
|
0.000308961
|
|
|
RA
|
[NCBI]
|
0.000223289
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
0.000174537
|
|
|
AD
|
[NCBI]
|
0.000170431
|
|
|
sitosterolemia
|
[NCBI]
|
0.000161531
|
|
|
fructose utilization
|
[NCBI]
|
0.000155619
|
|
|
ACHE
|
[NCBI]
|
0.00014145
|
|
|
hypercholesterolemia, autosomal dominant, type b
|
[NCBI]
|
0.000124053
|
|
|
triglyceride storage disease, type ii
|
[NCBI]
|
0.000124053
|
|
|
LNS
|
[NCBI]
|
0.000117067
|
|
|
EIG
|
[NCBI]
|
9.56291e-05
|
|
|
SLC7A5
|
[NCBI]
|
9.44706e-05
|
|
|
TS
|
[NCBI]
|
9.43959e-05
|
|
|
PD
|
[NCBI]
|
9.21131e-05
|
|
|
LPL
|
[NCBI]
|
8.68504e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
8.17592e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
7.9501e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
7.7451e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
7.55743e-05
|
|
|
CDS
|
[NCBI]
|
7.38441e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
7.38441e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
6.9343e-05
|
|
|
APRT
|
[NCBI]
|
6.90724e-05
|
|
|
PNKD1
|
[NCBI]
|
6.56086e-05
|
|
|
GTS
|
[NCBI]
|
6.4557e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
6.44932e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
6.34322e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
6.24205e-05
|
|
|
propionic acidemia
|
[NCBI]
|
6.05286e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
5.87892e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
5.87892e-05
|
|
|
GCE
|
[NCBI]
|
5.79695e-05
|
|
|
ABP1
|
[NCBI]
|
5.77285e-05
|
|
|
IVA
|
[NCBI]
|
5.49725e-05
|
|
|
DYT1
|
[NCBI]
|
5.49725e-05
|
|
|
MADD
|
[NCBI]
|
5.23461e-05
|
|
|
SLC7A8
|
[NCBI]
|
5.21276e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
5.05708e-05
|
|
|
PDS
|
[NCBI]
|
5.00109e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
4.79107e-05
|
|
|
SLE
|
[NCBI]
|
4.72358e-05
|
|
|
SLC18A3
|
[NCBI]
|
4.49228e-05
|
|
|
CDSP
|
[NCBI]
|
4.42595e-05
|
|
|
FTD
|
[NCBI]
|
4.34882e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.08097e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
3.84863e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
3.84863e-05
|
|
|
DCE
|
[NCBI]
|
3.72536e-05
|
|
|
DBA
|
[NCBI]
|
3.37843e-05
|
|
|
CF
|
[NCBI]
|
3.27794e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.0024e-05
|
|
|
TPO
|
[NCBI]
|
2.835e-05
|
|
|
PLTP
|
[NCBI]
|
2.76956e-05
|
|
|
SLC18A2
|
[NCBI]
|
2.70206e-05
|
|
|
FACL5
|
[NCBI]
|
2.52238e-05
|
|
|
THH
|
[NCBI]
|
2.52238e-05
|
|
|
PPAT
|
[NCBI]
|
2.38759e-05
|
|
|
SCD
|
[NCBI]
|
2.19261e-05
|
|
|
ABCC2
|
[NCBI]
|
2.14532e-05
|
|
|
LBP
|
[NCBI]
|
2.12704e-05
|
|
|
SLC2A5
|
[NCBI]
|
2.11486e-05
|
|
|
TNF
|
[NCBI]
|
2.10671e-05
|
|
|
PLCB2
|
[NCBI]
|
2.04826e-05
|
|
|
ABCG8
|
[NCBI]
|
2.04826e-05
|
|
|
PHYH
|
[NCBI]
|
1.93602e-05
|
|
|
VEGF
|
[NCBI]
|
1.8537e-05
|
|
|
ABCG2
|
[NCBI]
|
1.62659e-05
|
|
|
MDD
|
[NCBI]
|
1.55325e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
1.48926e-05
|
|
|
GDXY
|
[NCBI]
|
1.4103e-05
|
|
|
PF4
|
[NCBI]
|
1.41008e-05
|
|
|
SLC22A6
|
[NCBI]
|
1.35823e-05
|
|
|
ADH5
|
[NCBI]
|
1.29624e-05
|
|
|
TYMS
|
[NCBI]
|
1.22602e-05
|
|
|
ALD
|
[NCBI]
|
1.11437e-05
|
|
|
DAO
|
[NCBI]
|
1.0319e-05
|
|
|
CEL
|
[NCBI]
|
9.99094e-06
|
|
|
PARK2
|
[NCBI]
|
9.25871e-06
|
|
|
XDH
|
[NCBI]
|
9.18182e-06
|
|
|
MVP
|
[NCBI]
|
8.8072e-06
|
|
|
CP
|
[NCBI]
|
8.78066e-06
|
|
|
UGB
|
[NCBI]
|
8.2855e-06
|
|
|
LCT
|
[NCBI]
|
7.96859e-06
|
|
|
CLU
|
[NCBI]
|
7.86778e-06
|
|
|
SRC
|
[NCBI]
|
7.39586e-06
|
|
|
PWS
|
[NCBI]
|
7.31687e-06
|
|
|
APOB
|
[NCBI]
|
7.25613e-06
|
|
|
HBB
|
[NCBI]
|
7.21363e-06
|
|
|
ACE
|
[NCBI]
|
7.20053e-06
|
|
|
homocystinuria
|
[NCBI]
|
7.13558e-06
|
|
|
PCNA
|
[NCBI]
|
7.07264e-06
|
|
|
SI
|
[NCBI]
|
6.97048e-06
|
|
|
CRH
|
[NCBI]
|
6.6899e-06
|
|
|
HPRT1
|
[NCBI]
|
6.6211e-06
|
|
|
EPO
|
[NCBI]
|
6.29703e-06
|
|
|
VIP
|
[NCBI]
|
5.97412e-06
|
|
|
ABCB1
|
[NCBI]
|
5.87452e-06
|
|
|
TLR4
|
[NCBI]
|
5.64612e-06
|
|
|
NPY
|
[NCBI]
|
5.6446e-06
|
|
|
GC
|
[NCBI]
|
5.60527e-06
|
|
|
FGF2
|
[NCBI]
|
5.51952e-06
|
|
|
SLC2A4
|
[NCBI]
|
5.40807e-06
|
|
|
BDNF
|
[NCBI]
|
4.77636e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.29517e-06
|
|
|
COMT
|
[NCBI]
|
3.7081e-06
|
|
|
AFP
|
[NCBI]
|
3.67715e-06
|
|
|
CHAT
|
[NCBI]
|
3.63024e-06
|
|
|
AR
|
[NCBI]
|
3.54564e-06
|
|
|
MBP
|
[NCBI]
|
2.93153e-06
|
|
|
GAPDH
|
[NCBI]
|
2.92821e-06
|
|
|
SERPINA6
|
[NCBI]
|
2.88721e-06
|
|
|
PI
|
[NCBI]
|
2.65467e-06
|
|
|
CD
|
[NCBI]
|
2.53077e-06
|
|
|
HDC
|
[NCBI]
|
2.36698e-06
|
|
|
PNMT
|
[NCBI]
|
2.35656e-06
|
|
|
LDLR
|
[NCBI]
|
2.35656e-06
|
|
|
HBA1
|
[NCBI]
|
2.16674e-06
|
|
|
NGFB
|
[NCBI]
|
2.13977e-06
|
|
|
INS
|
[NCBI]
|
2.0636e-06
|
|
|
SHBG
|
[NCBI]
|
2.03733e-06
|
|
|
GFAP
|
[NCBI]
|
1.84686e-06
|
|
|
NPPA
|
[NCBI]
|
1.54634e-06
|
|
|
PTH
|
[NCBI]
|
1.42442e-06
|
|
|
ABCC1
|
[NCBI]
|
1.37196e-06
|
|
|
HD
|
[NCBI]
|
1.35286e-06
|
|
|
EGF
|
[NCBI]
|
1.28303e-06
|
|
|
MAG
|
[NCBI]
|
1.25463e-06
|
|
|
GHRH
|
[NCBI]
|
1.07009e-06
|
|
|
G6PD
|
[NCBI]
|
9.71155e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.61998e-07
|
|
|
MPO
|
[NCBI]
|
7.99991e-07
|
|
|
CJD
|
[NCBI]
|
6.76534e-07
|
|
|
ACP5
|
[NCBI]
|
5.92347e-07
|
|
|
TH
|
[NCBI]
|
5.51166e-07
|
|
|
ALB
|
[NCBI]
|
5.39587e-07
|
|
|
PYY
|
[NCBI]
|
4.55092e-07
|
|
|
VDR
|
[NCBI]
|
2.96981e-07
|
|
|
CCK
|
[NCBI]
|
2.76166e-07
|
|
|
TG
|
[NCBI]
|
2.4746e-07
|
|
|
EGFR
|
[NCBI]
|
2.36029e-07
|
|
|
APOE
|
[NCBI]
|
2.18734e-07
|
|
|
ADA
|
[NCBI]
|
1.57814e-07
|
|
|
TTR
|
[NCBI]
|
1.44086e-07
|
|
|
AHR
|
[NCBI]
|
1.66407e-08
|
|
|
KLK3
|
[NCBI]
|
2.26689e-09
|
|
|
PPARA
|
[NCBI]
|
7.41177e-10
|
|
|
GDNF
|
[NCBI]
|
2.13168e-10
|
|